16 October 2024
16 October 2024
The deal between the two companies aims to develop an artificial intelligence driven platform designed to cut out PET scans.
Momentis Surgical is expanding from the gynaecology surgery market to the general surgery market with the US Food and Drug Administration (FDA) 510(k) clearance.
The scheme between Chiesi and Health Innovation Manchester is designed to catch lung exacerbations earlier with the goal of saving the NHS £65m
RADGIL2 is an X-ray blood irradiator specifically designed to prevent transfusion-associated-graft versus host disease.
The FDA’s de novo clearance for the Versius surgical system builds on the European CE mark the system gained back in 2019.
The US robotics company is ramping up its go-to-market strategy ahead of potential US Food and Drug Administration (FDA) clearance in the second quarter of 2025 (Q2 2025).
The single-arm, multicentre trial targets patients with acute ischemic stroke caused by intracranial LVO.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
